The Board of Directors of Kaken Pharmaceutical Co., Ltd. has authorized a buyback plan on May 11, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,478 JPY | +0.03% | +2.08% | +3.67% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.67% | 861M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- 4521 Stock
- News Kaken Pharmaceutical Co., Ltd.
- Kaken Pharmaceutical Co., Ltd. authorizes a Buyback Plan.